P569: GILTERITINIB AND QUIZARTINIB IN RELAPSED/REFRACTORY (R/R) ACUTE MYELOBLASTIC LEUKEMIA (AML) WITH FLT3 MUTATIONS: A REAL-LIFE EFFECTIVENESS AND SAFETY STUDY. (23rd June 2022) - Quintela, D.; Morgades, M.; Serrano, A.; Cervera, M.; Balerdi, A.; Díaz-Beyá, M.; Arnan, M.; Garrido, A.; Coll, R.; Tormo, M.; López-Marin, J.; Merchan, B.; et al.